architecture

Robotic hydrocephalus surgery: A systematic review of the effectiveness in neurosurgical interventions

机器人辅助脑积水手术:神经外科干预有效性的系统综述

https://doi.org/10.1016/j.neuchi.2025.101677Get rights and content
Referred to by
Neurochirurgie, Volume 72, Issue 2, March 2026, Pages 101789
Paweł Łajczak, Anna Łajczak, Stanisław Buczkowski, Kamil Jóźwik, Przemysław Nowakowski
View PDF

Highlights

  • Hydrocephalus is a neurological condition characterizing the accumulation of cerebrospinal fluid in the brain’s ventricles.
  • Recently, robotic systems were introduced into hydrocephalus surgery, and studies show that robotic systems are accurate.
  • Almost all the studies showed robotic success with rare complications like minor bleeding or conversion to manual surgery.
  • Robotic assistance in hydrocephalus offers potential for advancement in achieving surgical precision and increased safety.

Abstract

Background

Hydrocephalus is an abnormal buildup of cerebrospinal fluid (CSF) deep within the brain, resulting in clinical symptoms, including disorientation, vision disturbances, headaches, cognitive and developmental impairment. Traditional non-navigated surgical treatment, with ventriculoperitoneal (VP) shunt and endoscopic third ventriculostomy (ETV), may lead to complications such as shunt obstruction and inaccurate catheter placement. Robotics-assisted (RA) surgery has potential to improve precision of procedures. The objective of this systematic review is to assess the clinical effectiveness, complications, and benefits of RA surgical interventions in the case of hydrocephalus.

Methods

PRISMA-guided literature search was done in databases including PubMed, Web of Science, Cochrane Reviews, Scopus, and Embase. Inclusion criteria encompassed English language, original, peer-reviewed journal articles in robotic-assisted surgical interventions in hydrocephalus. Patient demographics, robotic systems used, and results were extracted.

Results

In total, 12 of the articles discussed robotic-assisted interventions for hydrocephalus. The robotic systems used included ROSA, NaoTrac, Remebot, and more. The findings established that the robotic systems are accurate. Almost all the studies showed successful outcomes with minimum robot-related complications like minor bleeding or conversion to manual surgery.

Conclusions

The evidence supporting the use of robot-assisted surgery for hydrocephalus management remains very limited in the literature. There is currently insufficient evidence to suggest that it offers any significant additional benefits in terms of patient outcomes, safety, or cost-effectiveness compared to conventional neurosurgical methods. Moreover, given the high maintenance costs of robotic workstations and prolonged surgery times, well-designed prospective controlled trials are needed to evaluate robotic effectiveness, compared to navigation-based techniques.

背景

脑积水是指脑深部脑脊液(CSF)异常积聚的一种病症,由此引发的临床症状包括定向障碍、视力障碍、头痛以及认知和发育受损。传统的非导航辅助手术治疗方法——即脑室腹腔分流术(VP分流术)和内镜下第三脑室造瘘术(ETV)——可能导致分流管梗阻和导管置入位置不准确等并发症。机器人辅助(RA)手术有望提高手术操作的精准度。本系统综述旨在评估机器人辅助手术干预在治疗脑积水方面的临床有效性、并发症发生率及潜在获益。

方法

本研究依据PRISMA指南,对PubMed、Web of Science、Cochrane Reviews、Scopus和Embase等数据库进行了文献检索。纳入标准涵盖了针对脑积水进行机器人辅助手术干预的英文原创、经同行评审的期刊论文。研究人员提取了患者的人口学特征、所使用的机器人系统类型以及手术结果等数据。

结果

共计12篇文献探讨了机器人辅助干预在脑积水治疗中的应用。所使用的机器人系统包括ROSA、NaoTrac、Remebot等。研究结果证实,这些机器人系统具有较高的精准度。几乎所有研究均报告了成功的手术结局,且机器人相关的并发症极少,仅表现为轻微出血或需转为人工手术操作等情况。

结论

目前文献中支持使用机器人辅助手术治疗脑积水的证据依然十分有限。现有证据尚不足以表明,与传统的神经外科手术方法相比,机器人辅助手术在患者预后、安全性或成本效益方面具有任何显著的额外优势。此外,鉴于机器人工作站的高昂维护成本以及可能导致手术时间延长,亟需开展设计严谨的前瞻性对照试验,以便将机器人辅助手术与基于导航技术的传统手术进行对比,从而全面评估其临床有效性。

Introduction

Hydrocephalus is an abnormal buildup of cerebrospinal fluid (CSF) deep within the brain, resulting in clinical symptoms, including disorientation, vision disturbances, headaches, cognitive and developmental impairment [1].
Hydrocephalus can be simply divided into communicating and non-communicating subtypes. Communicating hydrocephalus is caused when there is an overproduction of CSF. Non-communicating hydrocephalus, on the other hand, occurs when there is a blockade of the pathway in the ventricular system, and CSF cannot normally proceed through the CNS.
Another classification is primary or secondary hydrocephalus. Primary hydrocephalus is a result of pathological fetal development, caused by various genetic factors [2], [3]. Secondary hydrocephalus can be a result of acute head injury, intracranial infection, or intracranial hemorrhage [4].
According to the systematic review performed by Isaacs et al., the prevalence of hydrocephalus is around 88 per 100,000 among children and 175 per 100,000 among the elderly [5]. Additionally, a lower incidence of this pathology was found among high-income countries.
There are various approaches for the management of hydrocephalus, including drug treatment and surgical procedures [6]. Surgical modalities include placement of an external ventricular drain (EVD), shunting (ventriculoperitoneal [VP], ventriculoatrial [VA], or lumboperitoneal [LP]), and endoscopic third ventriculostomy (ETV).
Both VP shunting and ETV are commonly used for the treatment of hydrocephalus. However, reliance on anatomical landmarks without assistance of navigation can lead to complications related to wrong trajectory of endoscope or catheter [7]. Therefore, an accurate navigation system is needed to prevent damage to healthy CNS structures.
Additionally, the ETV interventions may lead to fornical injuries, (hypo)thalamic contusion, nerve palsy, basilar artery damage, or neurological impairment when inaccurate endoscope manipulations are performed [8], [9], [10].
The neurosurgical field has undergone technological progress with the introduction of high-tech tools. Among them, neurosurgical robots have been applied in various neurosurgical and neuroradiological interventions, such as brain biopsy, cerebral aneurysm coiling, spinal instrumentation, deep brain stimulation surgery, stereoelectroencephalography surgery, and intracranial hemorrhage drain [11], [12], [13]. The aim of the robotic assistance (RA) technology is to provide a higher accuracy of the surgical procedures, through computer-assisted navigation and pre-operative planning.
With an increasing interest in robots in the neurosurgical field, to this date, no systematic review has analyzed the RA surgical management of hydrocephalus. We believe that this review provides a novel pathway and guidance, as we plan to analyze surgical approaches, complications of RA management, and clinical effectiveness. We also plan to provide advantages and disadvantages of robotic systems in the treatment of this neurological condition, compared to manual approaches.

Access through your organization

Check access to the full text by signing in through your organization.

Section snippets

Methodology

This systematic review followed the widely adopted reporting guidelines Preferred Reporting in Systematic Reviews and Meta-Analyses (PRISMA) [14].

Results

A systematic search was performed on August 2024. We found 228 articles from PubMed, 593 from Embase, 38 from Scopus, 36 from Cochrane Reviews, and 362 from Web of Science. A total of 1257 papers were imported into the ZOTERO bibliography manager. Bibliographic software identified 454 duplicate articles, which were removed before the screening process. A total of 803 articles underwent preliminary screening of the papers by two authors of this paper independently. We excluded 759 articles,

Discussion

Hydrocephalus is a disorder whereby there is an abnormally increased accumulation of cerebrospinal fluid, leading to various symptoms and clinical signs. Treatment methods for hydrocephalus include several surgical procedures involving the insertion of ventriculoperitoneal (VP) shunts and endoscopic third ventriculostomy (ETV). These procedures are associated with risks of complications related to inaccuracy during placement, shunt obstruction, and neurological damage due to operations, hence

Conclusion

The evidence supporting the use of robot-assisted surgery for hydrocephalus management remains very limited in the literature. There is currently insufficient evidence to suggest that it offers any significant additional benefits in terms of patient outcomes, safety, or cost-effectiveness compared to conventional neurosurgical methods. Moreover, given the high maintenance costs of robotic workstations and prolonged surgery times, well-designed prospective controlled trials are needed to